01—Abstract
Summary
Summary of the 8-K filed June 2, 2025. Cited figures are marked; the original filing is the authoritative source.
Amrize Ltd (NYSE/SIX: AMRZ), the North American building materials and building envelope business of Holcim Ltd, is preparing to become a standalone public company via a 100%a spin-off to Holcim shareholders.
The SEC declared the Form 10 registration statement effective on May 30, 2025. Holcim has set June 20, 2025 as the cum-dividend date, with each Holcim shareholder receiving one Amrize share for every Holcim share held at the close of business that day. Amrize shares are expected to begin standalone trading on June 23, 2025 on the NYSE and SIX under the ticker AMRZ, and Holcim shareholder approval was given at the May 14, 2025 AGM with 99.75%b in favor.
The business profile is substantial: roughly 19,000 employees across more than 1,000 sites in the U.S. and Canada, with two reportable segments, Building Materials (2024 revenue of $8.3 billionc) and Building Envelope ($3.4 billion). For 2024, carve-out results show revenue of $11.7 billion, operating income of $2.2 billion, net income attributable to the company of about $1.4 billion, and Adjusted EBITDA of $3.2 billion. Q1 2025 was weak, with a net loss of $55 million and operating loss of $21 million, reflecting seasonality and the cost of standing up the company.
Cash used in operating activities was $856 milliond in Q1 2025, versus $597 million a year earlier. The company is pairing the separation with a conservative balance sheet. S&P and Moody's rate Amrize BBB+ and Baa1, both with stable outlooks.
Amrize has arranged $3.4 billion of debt financing, including bonds, a $2 billion committed credit facility, and a $2 billion commercial paper program, with a $1.7 billion bridge loan available. Investors should weigh the expected benefits of focus and capital allocation against the risks of a carve-out with no standalone operating history, shared-service and indemnification arrangements with Holcim, and the cyclicality of construction end markets. Pro forma data show total equity of about $12.5 billion against roughly $9.8 billion of liabilities at March 31, 2025.
02—Key points
Key Highlights
- Spin-off mechanics: Holcim shareholders receive 1 AMRZ share for every 1 Holcim share held at close of business on June 20, 2025 (cum-dividend date); AMRZ begins standalone trading June 23, 2025 on NYSE and SIX.
- Scale: about 19,000 employees and more than 1,000 sites; largest U.S. and Canadian cement provider by sales and volume; second-largest commercial roofing company in North America.
- 2024 carve-out financials: revenue $11.7B, net income about $1.3B, Adjusted EBITDA $3.2B; Adjusted EBITDA grew from $2.6B in 2022.
- Q1 2025 was a seasonal loss: revenue $2.08B, net loss $55M, and operating cash outflow of $856M; investors should not extrapolate this quarter.
- Credit profile: investment-grade ratings of BBB+ (S&P) and Baa1 (Moody's), with $3.4B of debt financing secured, including a $2B revolver and $2B CP program.
- Index inclusion: Amrize expected to join the Swiss SMI and SLI indices on its first trading day, and will seek inclusion in relevant U.S. equity indices.
- Approvals and status: Form 10 declared effective May 30, 2025; Holcim shareholders approved with 99.75% in favor; distribution remains subject to customary conditions (NYSE/SIX listing, tax opinion, no material adverse developments).
03—Questions
Frequently Asked Questions
When and how will I receive Amrize shares if I own Holcim stock?
No action is required. Holders of Holcim shares as of the close of business on June 20, 2025 (the cum-dividend date) will receive one Amrize share for each Holcim share, distributed as a dividend-in-kind by UBS AG as Swiss settlement agent. Amrize shares are expected to begin trading on June 23, 2025, and Holcim shares keep trading under HOLN. Fractional shares will not be issued.
What is Amrize's business and how is it organized?
Amrize is the North American building solutions business carved out of Holcim, covering the U.S., Canada, and Jamaica. It has two segments: Building Materials ($8.3B of 2024 revenue, including cement, aggregates, ready-mix concrete, and asphalt) and Building Envelope ($3.4B, including commercial and residential roofing, insulation, and wall systems under brands such as Duro-Last, Elevate, and Malarkey).
What are the main risks for investors?
Key risks include Amrize's lack of standalone operating history, so carve-out financials may not represent future results as an independent company; cyclicality in construction demand and exposure to interest rates and inflation; energy and raw material costs; and reliance on transitional services and indemnification agreements with Holcim. Investors should also note the Q1 2025 net loss and negative operating cash flow, which reflect seasonality and separation costs. Tax-free treatment is based on an IRS private letter ruling and tax opinion that do not address every requirement.
How is Amrize capitalized at the spin-off?
Amrize has arranged about $3.4 billion of debt financing, including bonds, a $2B committed revolving credit facility, and a $2B commercial paper program, with a $1.7B bridge loan available. Ratings are BBB+ (S&P) and Baa1 (Moody's), both stable. Pro forma cash at March 31, 2025 was about $40 million, and pro forma total equity was about $12.5 billion. Management plans a U.S. dollar-based capital structure and growth-focused capital allocation, with dividend policy subject to Board discretion and Swiss law.
Who will lead Amrize and what does the company expect to deliver?
Jan Philipp Jenisch, currently Holcim's Chairman, will serve as Amrize's CEO and Chairman after the spin-off. Management targets growth above the market, margin expansion, and strong cash generation, with capital directed to investment in the business, value-accretive M&A, and shareholder returns. Specific mid-term financial targets were presented at Amrize's March 25, 2025 investor day and are not restated in this filing.
04—Continue